Biogen and Sage Therapeutics' zuranolone has become the first oral drug to be approved by the FDA for post-partum depression (PPD), but the US regulator turned down a request for wider use in the ...

However, it has a broader label as unlike J&J's drug it is indicated for use in previously-untreated MDD. Axsome's drug was given a breakthrough designation from the FDA, reflecting the need for new ...

Remission (MADRS total score ≤10) was seen in 65% of patients treated with lumateperone in combination with an oral antidepressant, at 6 months. The Food and Drug Administration (FDA) has approved ...

Major depressive disorder can be treated with different types of medications like SSRIs and SNRIs. The FDA warns that antidepressants may increase suicide risk in children and teens. Amitriptyline and ...

MMDAgent-EX is an open-source platform for voice dialogue systems and avatar communication. It is a standalone system that combines the display and control of CG characters with speech and language ...

MDD-5k is build upon 926 unique patient files, and each patient file is used to synthesize five diagnostic conversations, resulting in a total of 4630 conversations.